Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

S&P Biotech SPDR (XBI)

S&P Biotech SPDR (XBI)
88.46 x 8 88.80 x 40
Pre-market by (Cboe BZX)
88.82 +1.71 (+1.96%) 03/24/25 [NYSE Arca]
88.46 x 8 88.80 x 40
Pre-market 88.47 -0.35 (-0.39%) 06:42 ET
Quote Overview for Mon, Mar 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
85.74
Day High
87.50
Open 86.18
Previous Close 87.12 87.12
Volume 5,032,200 5,032,200
Avg Vol 8,366,275 8,366,275
Stochastic %K 69.36% 69.36%
Weighted Alpha -7.81 -7.81
5-Day Change +0.53 (+0.60%) +0.53 (+0.60%)
52-Week Range 81.14 - 105.47 81.14 - 105.47
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Price/Earnings ttm 17.88
  • Annual Dividend & Yield 0.13 (0.15%)
  • Most Recent Dividend 0.003 on 12/23/24
  • Management Fee 0.35%
  • INDUSTRY GROUPING:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 25.10% ( -2.63%)
  • Historical Volatility 22.10%
  • IV Percentile 14%
  • IV Rank 13.94%
  • IV High 38.19% on 08/05/24
  • IV Low 22.98% on 11/12/24
  • Put/Call Vol Ratio 0.58
  • Today's Volume 15,562
  • Volume Avg (30-Day) 39,557
  • Put/Call OI Ratio 1.61
  • Today's Open Interest 454,202
  • Open Int (30-Day) 576,736

Price Performance

See More
Period Period Low Period High Performance
1-Month
84.07 +5.65%
on 03/04/25
Period Open: 90.11
90.14 -1.46%
on 02/25/25
-1.29 (-1.43%)
since 02/24/25
3-Month
84.07 +5.65%
on 03/04/25
Period Open: 91.98
94.90 -6.41%
on 02/05/25
-3.16 (-3.44%)
since 12/24/24
52-Week
81.14 +9.47%
on 04/25/24
Period Open: 93.56
105.47 -15.79%
on 11/11/24
-4.74 (-5.07%)
since 03/22/24

Most Recent Stories

More News
Sarepta Therapeutics Stock Has A Nightmarish Week After DMD Patient Death, But Retail And Analysts Aren't Giving Up

Jefferies acknowledged acute liver failure could signal a new safety risk but maintained that the high unmet need for DMD treatments supports the bull case.

SRPT : 76.33 (+3.01%)
IJH : 60.26 (+2.48%)
VTI : 284.01 (+1.85%)
XBI : 88.82 (+1.95%)
Capricor Therapeutics Stock Surges After Q4 Results Beat Estimates: Retail Gets More Bullish

The company said its available cash, cash equivalents, and marketable securities will be sufficient to cover the expenses and capital requirements into 2027.

VTI : 284.01 (+1.85%)
XBI : 88.82 (+1.95%)
CAPR : 13.28 (+3.27%)
How Is Biogen's Stock Performance Compared to Other Biotech Stocks?

Despite Biogen's underperformance compared to other biotech stocks over the past year, analysts remain moderately optimistic about its future prospects.

GILD : 106.74 (-0.32%)
XBI : 88.82 (+1.95%)
BIIB : 141.60 (+0.50%)
Altimmune Shares Sink This Year, But Retail Traders See A Buyout On The Horizon

A Betaville report suggested Altimmune has begun a strategic review with an adviser, with speculation that three major pharmaceutical firms may be involved.

ALT : 6.05 (+4.13%)
VTI : 284.01 (+1.85%)
IWM : 208.86 (+2.49%)
XBI : 88.82 (+1.95%)
Sangamo Therapeutics Retail Traders Keep The Faith Even As Stock Slides After-Hours On Q4 Miss

Several optimistic users expressed confidence in the company securing a third potential agreement with a major pharma for its adeno-associated virus (AAV) capsid, STAC-BBB.

SGMO : 0.8700 (+0.39%)
VTI : 284.01 (+1.85%)
XBI : 88.82 (+1.95%)
SCHA : 24.53 (+2.55%)
SpringWorks Therapeutics Leads Biotech Pack In Weekly Retail Follower Surge: What's Fueling Interest?

Investor attention is now on whether Merck will confirm a formal offer as speculation over a potential acquisition continues dominating discussions around the stock.

VTI : 284.01 (+1.85%)
XBI : 88.82 (+1.95%)
IWM : 208.86 (+2.49%)
SWTX : 48.51 (-2.77%)
Capricor Therapeutics’ Retail Chatter Explodes On Stocktwits After FDA Grants Priority Review For DMD Therapy

The health agency has accepted Capricor's Biologics License Application for full approval of deramiocel as a treatment for Duchenne muscular dystrophy cardiomyopathy.

VTI : 284.01 (+1.85%)
XBI : 88.82 (+1.95%)
IWM : 208.86 (+2.49%)
CAPR : 13.28 (+3.27%)
Emergent BioSolutions Stock Sinks As Q4 Revenue Plunges 30%, But Retail Clings To Profit Swing

For the first quarter, Emergent forecasted revenue in the range of $200 million to $240 million, lower than an analyst estimate of $279 million.

EBS : 5.73 (+0.17%)
AVUV : 90.10 (+2.55%)
VTI : 284.01 (+1.85%)
XBI : 88.82 (+1.95%)
Retail Bets TG Therapeutics Stock Can Sustain Post-Earnings Gains Throughout The Week

Annual revenue from its MS drug, Briumvi, more than tripled, with U.S. net product revenue reaching $103.6 million in the fourth quarter and $310 million for the full year.

TGTX : 42.61 (-0.88%)
IJR : 108.01 (+2.51%)
VTI : 284.01 (+1.85%)
XBI : 88.82 (+1.95%)
Adma Biologics' Retail Traders Eye Higher Open After Blowout Q4, Strong Full-Year Outlook

CEO Adam Grossman highlighted a 65% year-over-year jump in total revenue and a staggering 309% increase in adjusted EBITDA for 2024.

IJR : 108.01 (+2.51%)
ADMA : 20.32 (+2.63%)
VTI : 284.01 (+1.85%)
XBI : 88.82 (+1.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

See More

Top 10 Holdings

Key Turning Points

3rd Resistance Point 90.60
2nd Resistance Point 89.79
1st Resistance Point 89.30
Last Price 88.82
1st Support Level 88.00
2nd Support Level 87.19
3rd Support Level 86.70

See More

52-Week High 105.47
Fibonacci 61.8% 96.18
Fibonacci 50% 93.31
Fibonacci 38.2% 90.43
Last Price 88.82
52-Week Low 81.14

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals